Skip to main content
. Author manuscript; available in PMC: 2012 Jan 1.
Published in final edited form as: Am J Med Genet A. 2011 Jan;155A(1):168–173. doi: 10.1002/ajmg.a.33760

TABLE I.

Penetrance of VHL Type 2A Manifestations Among Family 2 Informative Carriers

Penetrance by age 50 Cumulative penetrance
Pheo (n=56) 37 (66%) 37 (66%)
HB (n=53) 11 (21%) 12 (23%)
RA (n=54) 7 (13%) 9 (17%)
RCC (n=53) 1 (2%) 1 (2%)

Pheo, pheochromocytoma; HB, hemangioblastoma; RA, retinal angioma; RCC, renal cell carcinoma.